SYNCHROMED II
Report
- Report Number
- 3004209178-2014-15179
- Event Type
- Injury
- Date Received
- August 12, 2014
- Report Date
- July 22, 2014
- Manufacturer
- MDT PUERTO RICO OPERATIONS CO
- Product Code
- LKK
- PMA / PMN Number
- P860004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- OTHER
Narratives
CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 8709, SERIAL# (B)(4), IMPLANTED: (B)(6) 2004, PRODUCT TYPE: CATHETER. PRODUCT ID: 8709, SERIAL# (B)(4), IMPLANTED: (B)(6) 2004, EXPLANTED: (B)(6) 2014, PRODUCT TYPE: CATHETER. PRODUCT ID: NEU_UNKNOWN_CATH, SERIAL# UNKNOWN, PRODUCT TYPE: CATHETER. (B)(4).
ANALYSIS OF THE PUMP FOUND NO ANOMALY. ANALYSIS OF THE 8709 CATHETER REVEALED ACCEPTABLE TESTING AND THE CATHETER WAS INCOMPLETE AND RETURNED IN SEGMENTS. ANALYSIS OF THE UNKNOWN CATHETER/SC CONNECTOR FOUND CORING/TEAR AND CUTS IN THE SEAL. THERE WAS NO LEAK SEEN IN THE LAB AND NO LEAK ALLEGATION.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IT WAS REPORTED THE PUMP HAD BEEN ¿ACTING FUNKY¿ THE LAST TWO MONTHS. THE PATIENT HAD A NORMAL ¿CSD¿ ON (B)(6) AND THE PUMP WAS AT THE ELECTIVE REPLACEMENT INDICATOR (ERI). REPLACEMENT TOOK PLACE AND THE PATIENT WAS FEELING OVER-/UNDER-DOSING INTERMITTENTLY. SOME DAYS THE PATIENT WAS DROWSY AND SOME DAYS THERE WAS INCREASED PAIN. THE PATIENT HAD OVERDOSE SYMPTOMS AND ¿WOULD FEEL HIGH.¿ THE PATIENT ALSO HAD CHRONIC LOW BACK PAIN. THIS STARTED TWO MONTHS AGO. THE PUMP WAS EXPLANTED AND REPLACED. THERE WAS A CATHETER ISSUE WHICH REQUIRED PARTIAL EXPLANT. THERE WAS SOME ¿CHALKY LOOK¿ IN THE PUMP POCKET AND THE PHYSICIAN RECOMMENDED REPLACING THE CATHETER PUMP SEGMENT AND RETURNING IT FOR ANALYSIS. THE CATHETER WAS TRIMMED 8.5 CENTIMETERS AND A NEW CATHETER SEGMENT WAS ADDED WITH CEREBROSPINAL FLUID (CSF) FLOW FROM THE CATHETER. A DYE STUDY AND X-RAYS WERE DONE AND THE LOGS WERE CHECKED. AN MRI WAS DONE ON JULY 18 (DURING WHICH TIME A MOTOR STALL AND MOTOR STALL RECOVERY WERE SEEN WITH A 47 MINUTE STALL DURATION). THE CATHETER PRODUCT ISSUE WAS RESOLVED. THE SYSTEM WAS BEING USED TO DELIVER MORPHINE AND FENTANYL. ON (B)(6) 2014 THE MORPHINE DOSE WAS DECREASED TO 9.990 MILLIGRAMS PER DAY FROM 13.043 MILLIGRAMS PER DAY. THE FENTANYL DOSE WAS DECREASED FROM 250.82 MICROGRAMS PER DAY TO 192.11 MICROGRAMS PER DAY. IT WAS LATER REPORTED THE CATHETER DYE STUDY AND X-RAY RESULTS WERE ALL NORMAL. THE PATIENT WAS PRESCRIBED 15 MILLIGRAM (MG) TABLETS OF MORPHINE AND 5 MG TABLETS OXYCODONE, BOTH TAKEN AS NEEDED. THE ACTUAL FREQUENCY IN WHICH THE PATIENT TOOK THEM WAS UNKNOWN. THE REASON FOR THE ISSUES THAT THE PATIENT EXPERIENCED WAS NOT KNOWN. THE PATIENT WAS BEING MONITORED. IT WAS NOT KNOWN HOW THE PATIENT WAS DOING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 478510 | SYNCHROMED II | PUMP, INFUSION, IMPLANTED, PROGRAMMABLE | LKK | MDT PUERTO RICO OPERATIONS CO | 863720 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |